Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rehm

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Cell Death and Differentiation|September 23, 2008
Role of Smac in cephalostatin-induced cell deathA Rudy, N López-Antón, N Barth, et al.
European Journal of Pain (London, England)|April 2, 2015
No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trialJ Fleckenstein, N Kohls, E Evtouchenko, et al.
Cell Death & Disease|May 18, 2013
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approachÁ C Murphy, B Weyhenmeyer, J Schmid, et al.
British Journal of Cancer|December 15, 2015
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2020
New hints towards a precision medicine strategy for IDH wild-type glioblastomaK White, K Connor, J Clerkin, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Cell Death and Differentiation|September 23, 2008
Role of Smac in cephalostatin-induced cell deathA Rudy, N López-Antón, N Barth, et al.
European Journal of Pain (London, England)|April 2, 2015
No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trialJ Fleckenstein, N Kohls, E Evtouchenko, et al.
Cell Death & Disease|May 18, 2013
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approachÁ C Murphy, B Weyhenmeyer, J Schmid, et al.
British Journal of Cancer|December 15, 2015
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2020
New hints towards a precision medicine strategy for IDH wild-type glioblastomaK White, K Connor, J Clerkin, et al.
Pageof 10